Treace Medical Concepts, Inc. Amortization of Debt Issuance Costs
Treace Medical Concepts, Inc. (TMCI) reported Amortization of Debt Issuance Costs of $505.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2026-08-07
- Treace Medical Concepts, Inc. amortization of debt issuance costs for the quarter ending 2026-06-30 was $243.00K, a 228.38% increase year-over-year.
- Treace Medical Concepts, Inc. amortization of debt issuance costs for the quarter ending 2026-03-31 was $262.00K, a 254.05% increase year-over-year.
- Treace Medical Concepts, Inc. amortization of debt issuance costs for the quarter ending 2025-12-31 was $69.00K, a 8.00% decline year-over-year.
- Treace Medical Concepts, Inc. amortization of debt issuance costs for the quarter ending 2025-09-30 was $75.00K, a 1.35% increase year-over-year.
- Treace Medical Concepts, Inc. amortization of debt issuance costs for fiscal 2025 was $292.00K, a 2.01% decline from fiscal 2024.
- Treace Medical Concepts, Inc. amortization of debt issuance costs for fiscal 2024 was $298.00K, a 0.34% increase from fiscal 2023.
- Treace Medical Concepts, Inc. amortization of debt issuance costs for fiscal 2023 was $297.00K, a 21.72% increase from fiscal 2022.
- Treace Medical Concepts, Inc. amortization of debt issuance costs for fiscal 2022 was $244.00K, a 38.64% increase from fiscal 2021.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 9 month | Amortization of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2026-06-30 | $243.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $505.00K 10-Q · filed 2026-08-07 | $574.00K derived: sum of 3 quarters · filed 2026-08-07 | $649.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $262.00K 10-Q · filed 2026-05-08 | $331.00K derived: sum of 2 quarters · filed 2026-05-08 | $406.00K derived: sum of 3 quarters · filed 2026-05-08 | $480.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $69.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $144.00K derived: sum of 2 quarters · filed 2026-02-27 | $218.00K derived: sum of 3 quarters · filed 2026-08-07 | $292.00K 10-K · filed 2026-02-27 |
| 2025-09-30 | $75.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $149.00K derived: sum of 2 quarters · filed 2026-08-07 | $223.00K 10-Q · filed 2025-11-06 | $298.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $74.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $148.00K 10-Q · filed 2026-08-07 | $223.00K derived: sum of 3 quarters · filed 2026-08-07 | $297.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $74.00K 10-Q · filed 2026-05-08 | $149.00K derived: sum of 2 quarters · filed 2026-05-08 | $223.00K derived: sum of 3 quarters · filed 2026-05-08 | $297.00K derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $75.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $149.00K derived: sum of 2 quarters · filed 2026-02-27 | $223.00K derived: sum of 3 quarters · filed 2026-02-27 | $298.00K 10-K · filed 2026-02-27 |
| 2024-09-30 | $74.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $148.00K derived: sum of 2 quarters · filed 2025-11-06 | $223.00K 10-Q · filed 2025-11-06 | $297.00K derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $74.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $149.00K 10-Q · filed 2025-08-07 | $223.00K derived: sum of 3 quarters · filed 2026-02-27 | $298.00K derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $75.00K 10-Q · filed 2025-05-08 | $149.00K derived: sum of 2 quarters · filed 2026-02-27 | $224.00K derived: sum of 3 quarters · filed 2026-02-27 | $298.00K derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $74.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $149.00K derived: sum of 2 quarters · filed 2026-02-27 | $223.00K derived: sum of 3 quarters · filed 2026-02-27 | $297.00K 10-K · filed 2026-02-27 |
| 2023-09-30 | $75.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $149.00K derived: sum of 2 quarters · filed 2024-11-05 | $223.00K 10-Q · filed 2024-11-05 | $298.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $74.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $148.00K 10-Q · filed 2024-08-06 | $223.00K derived: sum of 3 quarters · filed 2025-02-27 | $297.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $74.00K 10-Q · filed 2024-05-07 | $149.00K derived: sum of 2 quarters · filed 2025-02-27 | $223.00K derived: sum of 3 quarters · filed 2025-02-27 | $273.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $75.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $149.00K derived: sum of 2 quarters · filed 2025-02-27 | $199.00K derived: sum of 3 quarters · filed 2025-02-27 | $244.00K 10-K · filed 2025-02-27 |
| 2022-09-30 | $74.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $124.00K derived: sum of 2 quarters · filed 2023-11-09 | $169.00K 10-Q · filed 2023-11-09 | $212.00K derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $50.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $95.00K 10-Q · filed 2023-08-09 | $138.00K derived: sum of 3 quarters · filed 2024-02-27 | $183.00K derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $45.00K 10-Q · filed 2023-05-09 | $88.00K derived: sum of 2 quarters · filed 2024-02-27 | $133.00K derived: sum of 3 quarters · filed 2024-02-27 | $178.00K derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $43.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $88.00K derived: sum of 2 quarters · filed 2024-02-27 | $133.00K derived: sum of 3 quarters · filed 2024-02-27 | $176.00K 10-K · filed 2024-02-27 |
| 2021-09-30 | $45.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $90.00K derived: sum of 2 quarters · filed 2022-11-09 | $133.00K 10-Q · filed 2022-11-09 | $185.00K derived: sum of 4 quarters · filed 2023-03-08 |
| 2021-06-30 | $45.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $88.00K 10-Q · filed 2022-08-10 | $140.00K derived: sum of 3 quarters · filed 2023-03-08 | $190.00K derived: sum of 4 quarters · filed 2023-03-08 |
| 2021-03-31 | $43.00K 10-Q · filed 2022-05-06 | $95.00K derived: sum of 2 quarters · filed 2023-03-08 | $145.00K derived: sum of 3 quarters · filed 2023-03-08 | $198.00K derived: sum of 4 quarters · filed 2023-03-08 |
| 2020-12-31 | $52.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $102.00K derived: sum of 2 quarters · filed 2023-03-08 | $155.00K derived: sum of 3 quarters · filed 2023-03-08 | $220.00K 10-K · filed 2023-03-08 |
| 2020-09-30 | $50.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $103.00K derived: sum of 2 quarters · filed 2021-11-04 | $168.00K 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $53.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $118.00K 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | $65.00K 10-Q · filed 2021-05-25 | |||
| 2019-12-31 | $147.00K 10-K · filed 2022-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |